Veradigm Inc. · OTC:MDRX
Veradigm — Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2019
24 slides from Veradigm's conference presentation, Jan 7, 2019
Slide 1: Allscripts Healthcare Solutions – J.P. Morgan Healthcare Conference
Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Exhibit 99.1
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including the statements under “Financial Model and Long Term Outlook”. These forward-looking statements are based on the current beliefs and expectations of A
Slide 3: Allscripts Today: A Business Transformed
Allscripts Today: A Business Transformed P A S T Experienced leadership team Shift to subscription based revenue Gaps in EHR solution set Increased leverage to drive strategic investments Complex financial reporting Focus on provider end markets Consolidator of EHR platforms Investments in culture P
Slide 4: Strong Financial Performance (Excluding Netsmart)
Dollars in millions. See reconciliation of non-GAAP metrics in the appendix of this presentation and on the Allscripts investor relations website. 2018 estimates based on low end of 2018 outlook provided on November 1, 2018. Strong Financial Performance (Excluding Netsmart) NON-GAAP REVENUE ~6 % C A
Slide 5: History of Meeting Commitments
History of Meeting Commitments See reconciliation of non-GAAP metrics in the appendix of this presentation and on the Allscripts investor relations website. NON-GAAP EPS GUIDANCE $0.42 - $0.50 $0.55 - $0.62 $0.61 - $0.63 ACTUAL NON-GAAP EPS $0.47 $0.55 $0.62 YEAR 2015 2016 2017
Slide 6: Efficient Capital Deployment
Efficient Capital Deployment… $272M RETURNED TO SHAREHOLDERS Repurchased 23 million shares $213 million remaining under current authorization as of 12/31/18 $0M (FREE) M&A 12 acquisitions/investments 2 divestitures Added: $300M, net in annual recurring revenue Growth platforms in: Care coordination
Slide 7: Positioned Allscripts to be a Long-Term Winner
…Positioned Allscripts to be a Long-Term Winner Source: Company filings, Nasdaq consensus estimates for CERN, ATHN, NXGN, CPSI as of 12/13/18, https://www.healthcare-informatics.com/hci100/2018-hci-100-list ~ Assumes low end of 2018 revenue guidance as provided on November 1, 2018, excluding Netsmar
Slide 8: Future Growth
Future Growth
Slide 9: Healthcare Provider Software and Services
Healthcare Provider Software and Services Healthcare provider IT spending is projected to increase over the next 5 years, regardless of how the economy performs (shift from fee for service to value based) Dollars in billions. Source: Gartner ~$120B GLOBAL HEALTHCARE IT MARKET IN 2019 HEALTHCARE PROV
Slide 10: EHRs are a Mature Market
EHRs are a Mature Market What will providers be buying? 01 02 03 04 05 06 07 Consumer / Patient Engagement Solutions Financial Decision Support Systems, Real-Time Resource Allocation Care Coordination between Traditional and Post-Acute Care Personalized Medicine Solutions Predictive Analytics and Op
Slide 11: Allscripts is Well Positioned in These Areas
Allscripts is Well Positioned in These Areas A R E A S B E S T I N C L A S S C O M P E T I T I V E Patient Engagement Financial Decision Support Care Coordination Personalized Medicine Predictive Analytics and Optimization Revenue Cycle Solutions and Services Clinical and Practice Management Solutio
Slide 12: Payer & Life Sciences Market Size & Growth
Payer & Life Sciences Market Size & Growth The payer & life sciences market is larger than the provider software market today, and growing at more than twice the rate 5% 22% 12% 14% 10% 5- YEA R CAGR $2.5B Medication therapy mgmt. $4.1B Healthcare analytics $2.0B Provider messaging $1.4B Provider an
Slide 13: Payer & Life Sciences End Markets are Growing Rapidly
Payer & Life Sciences End Markets are Growing Rapidly What will these companies be buying? Connectivity to Providers and Patients Insights and Analytics Real World Clinical Evidence
Slide 14: Veradigm Core Solutions
Veradigm Core Solutions We are far ahead of any other traditional EHR competitor in delivering value to these end markets Promotional Messaging Rx Price Transparency and pre-authorizations Lab Network eChartCourier (Electronic Chart Retrieval) Payer Gaps in Care messaging and pre-authorizations Risk
Slide 15: Financial Model and Long-Term Outlook
Financial Model and Long-Term Outlook
Slide 16: Top Line Growth Derived Across Our Different End Markets
Top Line Growth Derived Across Our Different End Markets 3 Year (2019-2021) Non-GAAP Revenue CAGR 3 Y E A R (2019-2021) R E V E N U E C A G R R E L A T I V E S I Z E W E I G H T E D I M P A C T Provider ~2-4% ~90% ~2.0 – 3.5 Veradigm ~15-25% ~10% ~1.5 – 2.5 Organic Non-GAAP Revenue CAGR 3.5% – 6.0%
Slide 17: Investment Considerations
Investment Considerations We enable providers, payers and life science companies to optimize value at the point of care High recurring revenue model Flexible balance sheet with capacity for investment and capital returns Robust, diversified and award winning solutions portfolio Significant operating
Slide 18: Allscripts Healthcare Solutions – J.P. Morgan Healthcare Conference
Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference
Slide 19: Appendix: Non-GAAP Reconciliations
Appendix: Non-GAAP Reconciliations
Slide 20: Non-GAAP Financial Measures
Non-GAAP Financial Measures This presentation includes references to non-GAAP revenue, non-GAAP earnings per share, Adjusted EBITDA, and free cash flow, which are considered non-GAAP financial measures under Section 101 of Regulation G under the Securities Exchange Act of 1934, as amended. Each of t
Slide 21: Reconciliations: Non-GAAP Revenue and Adjusted EBITDA
Reconciliations: Non-GAAP Revenue and Adjusted EBITDA
Slide 22: Reconciliations: Non-GAAP EPS 2017 and 2016
Reconciliations: Non-GAAP EPS 2017 and 2016
Slide 23: Reconciliations: Non-GAAP EPS 2015
Reconciliations: Non-GAAP EPS 2015
Slide 24: Reconciliations: Free Cash Flow
Reconciliations: Free Cash Flow
Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2019 on 6ix